|
Volumn 28, Issue 1, 2010, Pages 111-112
|
Bevacizumab may be active in myelofibrosis
|
Author keywords
Bevacizumab; Myelofibrosis; Myeloproliferative disorders
|
Indexed keywords
BEVACIZUMAB;
HYDROXYUREA;
AGED;
ARTICLE;
BONE MARROW BIOPSY;
CASE REPORT;
COUGHING;
DRUG DOSE REDUCTION;
DRUG EFFECT;
DRUG RESPONSE;
DYSPNEA;
EPISTAXIS;
FEMALE;
HEART TAMPONADE;
HUMAN;
HUMAN TISSUE;
LEUKOCYTE COUNT;
LEUKOCYTOSIS;
LUNG ADENOCARCINOMA;
LUNG BIOPSY;
LUNG NON SMALL CELL CANCER;
MONOTHERAPY;
MYELOID METAPLASIA;
MYELOPROLIFERATIVE DISORDER;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
WEIGHT REDUCTION;
AGED;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
CARCINOMA, NON-SMALL-CELL LUNG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
HYDROXYUREA;
INFUSIONS, PARENTERAL;
LEUKOCYTE COUNT;
LUNG NEOPLASMS;
PRIMARY MYELOFIBROSIS;
TREATMENT OUTCOME;
|
EID: 72449212253
PISSN: 07357907
EISSN: 15324192
Source Type: Journal
DOI: 10.3109/07357900902918502 Document Type: Article |
Times cited : (2)
|
References (5)
|